Jan 10, 2023 / 10:15PM GMT
Ekaterina V. Knyazkova - JPMorgan Chase & Co, Research Division - Analyst
Good afternoon, everybody. I'm Ekaterina Knyazkova at JPMorgan, and it is my pleasure to be introducing the Amneal team today. So from the company, we have co-CEO, Chirag Patel, who will be doing a presentation, and then we'll jump into Q&A. So Chirag, Happy New Year. Thank you for joining us and look forward to your remarks.
Chirag K. Patel - Amneal Pharmaceuticals, Inc. - Co-Founder, Co-CEO, President & Director
Thank you, Ekaterina. Very nice to be here. Is this yours? Good afternoon, everybody, and wishing you excellent 2023. We can all use that. And many good years to come by. I know it's a monsoon kind of season outside. I don't know if you saw it around 1:00, it was pouring down. So my name is Chirag Patel. I'm a co-founder and co-CEO of Amneal. It's been a fascinating journey.
It started 20 years ago. So I'm going to walk you through the history a little bit before we jump into where we stand today. It was a very humble beginning. In 2002 in Paterson New Jersey
Amneal Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
